Literature DB >> 25900480

Interventional MRI-guided local delivery of agents into swine bile duct walls using MR-compatible needle-integrated balloon catheter system.

Feng Zhang1, Zhibin Bai1, Yaoping Shi1, Jianfeng Wang1, Yonggang Li1, Xiaoming Yang1.   

Abstract

The purpose of this study was to investigate the feasibility of interventional MRI-guided local agent delivery into pig common bile duct (CBD) walls using a newly designed MR-compatible, needle-integrated balloon catheter system. We first designed a needle-integrated balloon catheter system that comprised of a 22 G MR-compatible Chiba biopsy needle and a conventional 12 mm × 2 cm balloon catheter. Under fluoroscopy guidance, a custom needle-balloon system was positioned in the target CBD via a transcholecystic access. T1-weighted MRI was used to localize and reposition the needle-balloon system in the target. A 0.5 mL mixture of motexafin gadolinium (MGd) and trypan blue dye as well as 5-fluorouracil was delivered into the CBD wall through the needle-balloon system. Post-infusion T1-weighted MRI was obtained and contrast-to-noise ratios (CNRs) of CBD walls of pre- and post-MGd-blue infusions were compared by a paired t-test. In addition, post-infusion x-ray cholangiography was achieved to evaluate the potential injuries of CBDs by the needle-balloon system. Subsequent histologic analysis was performed to correlate and confirm the imaging findings. A post-infusion cholangiogram did not show any extravasation of contrast agent, indicating no procedure-related damage to the CBDs. MRI demonstrated clear enhancement of the target bile duct walls infused with MGd-trypan blue dye with average penetration depth of 4.7 ± 1.2 mm and an average MGd perfusion length of 21 ± 1.5 mm in the bile ducts and their surrounding tissues. The average CNR of the post-infusion bile ducts was significant higher than that of the pre-infusion bile ducts (110.6 ± 22 versus 5.7 ± 2.8, p < 0.0001). Histology depicted the blue dye staining and red fluorescence of MGd through the target CBD walls, which was well correlated with the imaging findings. It is feasible to use the new MR-compatible, needle-integrated balloon catheter system for intrabiliary local agent delivery into CBD walls under MRI guidance, which may open new avenues for efficient management of pancreatobiliary malignancies using MR-guided interventional oncology.
Copyright © 2015 John Wiley & Sons, Ltd.

Entities:  

Keywords:  Cancer; Chemotherapeutic drug; Interventional MRI; Local delivery; Pancreatobiliary

Mesh:

Substances:

Year:  2015        PMID: 25900480      PMCID: PMC4441522          DOI: 10.1002/nbm.3308

Source DB:  PubMed          Journal:  NMR Biomed        ISSN: 0952-3480            Impact factor:   4.044


  20 in total

1.  Magnetic resonance imaging permits in vivo monitoring of catheter-based vascular gene delivery.

Authors:  X Yang; E Atalar; D Li; J M Serfaty; D Wang; A Kumar; L Cheng
Journal:  Circulation       Date:  2001-10-02       Impact factor: 29.690

Review 2.  Imaging of vascular gene therapy.

Authors:  Xiaoming Yang
Journal:  Radiology       Date:  2003-05-08       Impact factor: 11.105

3.  New metallic MR stents for artifact-free coronary MR angiography: feasibility study in a swine model.

Authors:  Arno Buecker; Elmar Spuentrup; Alexander Ruebben; Andreas Mahnken; Trung Hieu Nguyen; Sylvia Kinzel; Rolf W Günther
Journal:  Invest Radiol       Date:  2004-05       Impact factor: 6.016

4.  MR-guided percutaneous intramyocardial injection with an MR-compatible catheter: feasibility and changes in T1 values after injection of extracellular contrast medium in pigs.

Authors:  Gabriele A Krombach; Joachim G Pfeffer; Sylvia Kinzel; Markus Katoh; Rolf W Günther; Arno Buecker
Journal:  Radiology       Date:  2005-05       Impact factor: 11.105

5.  Magnetic resonance-guided cardiac interventions using magnetic resonance-compatible devices: a preclinical study and first-in-man congenital interventions.

Authors:  Aphrodite Tzifa; Gabriele A Krombach; Nils Krämer; Sascha Krüger; Adrian Schütte; Matthias von Walter; Tobias Schaeffter; Shakeel Qureshi; Thomas Krasemann; Eric Rosenthal; Claudia A Schwartz; Gopal Varma; Alexandra Buhl; Antonia Kohlmeier; Arno Bücker; Rolf W Günther; Reza Razavi
Journal:  Circ Cardiovasc Interv       Date:  2010-11-23       Impact factor: 6.546

6.  Motexafin gadolinium: a redox active drug that enhances the efficacy of bleomycin and doxorubicin.

Authors:  R A Miller; K W Woodburn; Q Fan; I Lee; D Miles; G Duran; B Sikic; D Magda
Journal:  Clin Cancer Res       Date:  2001-10       Impact factor: 12.531

Review 7.  Recent progress in pancreatic cancer.

Authors:  Christopher L Wolfgang; Joseph M Herman; Daniel A Laheru; Alison P Klein; Michael A Erdek; Elliot K Fishman; Ralph H Hruban
Journal:  CA Cancer J Clin       Date:  2013-07-15       Impact factor: 508.702

8.  Magnetic resonance--guided coronary artery stent placement in a swine model.

Authors:  Elmar Spuentrup; Alexander Ruebben; Tobias Schaeffter; Warren J Manning; Rolf W Günther; Arno Buecker
Journal:  Circulation       Date:  2002-02-19       Impact factor: 29.690

9.  Development of an intrabiliary MR imaging-monitored local agent delivery technique: a feasibility study in pigs.

Authors:  Feng Zhang; Jiakai Li; Yanfeng Meng; Jihong Sun; Stephanie S Soriano; Patrick Willis; Huidong Gu; David Glickerman; Xiaoming Yang
Journal:  Radiology       Date:  2012-03       Impact factor: 11.105

10.  MR-guided prostate biopsy for planning of focal salvage after radiation therapy.

Authors:  Cynthia Ménard; Douglas Iupati; Julia Publicover; Jenny Lee; Jessamine Abed; Gerald O'Leary; Anna Simeonov; Warren D Foltz; Michael Milosevic; Charles Catton; Gerard Morton; Robert Bristow; Andrew Bayley; Eshetu G Atenafu; Andrew J Evans; David A Jaffray; Peter Chung; Kristy K Brock; Masoom A Haider
Journal:  Radiology       Date:  2014-09-08       Impact factor: 11.105

View more
  2 in total

Review 1.  Clinical Considerations of Focal Drug Delivery in Cancer Treatment.

Authors:  Jamie Harris; Samuel C Klonoski; Bill Chiu
Journal:  Curr Drug Deliv       Date:  2017       Impact factor: 3.758

Review 2.  Multimodal molecular imaging evaluation for early diagnosis and prognosis of cholangiocarcinoma.

Authors:  Jiong Liu; Wen Xiu Ren; Jian Shu
Journal:  Insights Imaging       Date:  2022-01-20
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.